Spero will now have funding to start a new phase 3 trial of the drug – tebipenem pivoxil hydrobromide, to give it its full name – and according to GSK this will be designed based on feedback ...

Enero Group has today announced its results for the six months ended 31 December 2024, seeing EBITDA in the Technology, Healthcare and Consumer (THC) Practice grow 17% in FY25 H1 compared to FY24 H2.

Bloomberg reported this morning that GSK has sent out an “information memorandum with preliminary details about the business to possible suitors”. The website’s sources name a few bidders ...

New findings from a recent white paper highlight the economic and healthcare burden posed by Respiratory Syncytial Virus (RSV ...

An expert in connective tissue disease–associated interstitial lung disease described best approaches for rheumatologists to ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter and the full year ...

The Indian QR coding programme meant to protect domestic drug supplies has failed, and is now a gift to the counterfeiters.

US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238.6 million in FY 2024, up 10% and 8%, respectively ...

AL002 misses Phase 2 goal in early Alzheimer's. Key Phase 3 data for latozinemab in 2025. Click here to read why ALEC is a ...

The maiden Fortune India MNC 500 showcases India's largest multinationals, with a cumulative total income of ₹36.77 lakh cr ...